Issues in the use of inhaled glucocorticoids

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1739-1748

  Kamada, Alan K ^a   Szefler, Stanley J ^a   Martin, Richard J ^a   Boushey, Homer A ^a   Chinchilli, Vernon M ^a   Drazen, Jeffrey M ^a   Fish, James E ^a   Israel, Elliot ^a   Lazarus, Stephen C ^a   Lemanske, Robert F ^a   Cherniak, Reuben M ^a   Hurd, Suzanne S ^a   Peters, Stephen P ^a   Sorkness, Christine ^a   Zwillich, Clifford W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE PROPIONATE; PREDNISOLONE; TRIAMCINOLONE ACETONIDE;

ADRENAL INSUFFICIENCY; ASTHMA; BRONCHODILATATION; CORTICOSTEROID THERAPY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; GROWTH RETARDATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 8944259441     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665030     Document Type: Review

References (86)

1. Gaddie, J., I. W. Reid, C. Skinner, G. R. Petrie, D. J. M. Sinclair, and K. N. V. Palmer. 1973. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet ii:280-281.
2. Toogood, J. H., N. M. Lefcoe, D. S. M. Haines, B. Jennings, N. Errington, L. Baksh, and L. Chuang. 1977. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J. Allergy Clin. Immunol. 59:298-308.
3. Hummel, S., L. Lehtonen, and Study Group. 1992. Comparison of oral steroid-sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 340:1483-1487.
4. Grimfeld, A., A. Baculard, P. Barbier, M. Boulé, J. Just, and J. L. Desfourgères. 1993. Dose-effect relationship of beclomethasone dipropionate in moderate to severe childhood asthma (abstract). Eur. Respir. J. 17(Suppl.):358s.
5. McCubbin, M. M., G. Milavetz, S. Grandgeorge, M. Weinberger, R. Ahrens, C. Sargent, and L. Vaughan. 1995. A bioassay for topical and systemic effect of three inhaled corticosteroids. Clin. Pharmacol. Ther. 57:455-460.
6. Toogood, J. H., J. Baskerville, B. Jennings, N.M. Lefcoe, and S.-A. Johansson. 1989. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J. Allergy Clin. Immunol. 84:688-700.
7. Pedersen, S., and O. R. Hansen. 1995. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J. Allergy Clin. Immunol. 95:29-33.
8. Nelson, H. S., and the Pulmicort Turbuhaler Study Group. 1994. Steroid sparing effect of Pulmicort® (budesonide) Turbuhaler® in patients with chronic oral steroid-dependent asthma (abstract). Am. J. Respir. Crit. Care Med. 149:A213.
9. Doull, I. J. M., N. J. Freezer, and S. T. Holgate. 1993. Growth of asthmatic children on inhaled corticosteroids (abstract). Am. Rev. Respir. Dis. 147:A265.
10. Littlewood, J. M., A. W. Johnson, P. A. Edwards, and A. E. Littlewood. 1988. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet i:115-116.
11. Wales, J. K. H., N. D. Barnes, and P. G. F. Swift. 1991. Growth retardation in children on steroids for asthma. Lancet 338:1535-1536.
12. Graff-Lonnevig, V., and S. Kraepelien. 1979. Long-term treatment with beclomethasone dipropionate aerosol in asthmatic children, with special reference to growth. Allergy 34:57-61.
13. Bhan, G. L., C. M. Gwynn, and J. Morrison Smith. 1980. Growth and adrenal function of children on prolonged beclomethasone dipropionate treatment. Lancet i:96-97.
14. Balfour-Lynn, L. 1986. Growth and childhood asthma. Arch. Dis. Child 61:1049-1055.
15. Tinkleman, D. G., C. E. Reed, H. S. Nelson, and K. P. Offord. 1993. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 92:64-77.
16. Ellis, E. F. 1987. Adverse effects of corticosteroid therapy. J. Allergy Clin. Immunol. 80:515-517.
17. Allen, D. B., M. Mullen, and B. Mullen. 1994. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J. Allergy Clin. Immunol. 93:967-976.
18. Wolthers, O. D., and S. Pedersen. 1990. Short term linear growth in asthmatic children during treatment with prednisolone. B.M.J. 301: 145-148.
19. Mackenzie, C. A., and J. K. H. Wales. 1993. Knemometry and its practical application. Eur. Respir. Rev. 3:213-325.
20. Wolthers, O. D., and S. Pedersen. 1991. Growth of asthmatic children during treatment with budesonide: a double blind trial. B.M.J. 303: 163-165.
21. Wolthers, O. D., and S. Pedersen. 1992. Controlled study of linear growth in asthmatic children during treatment with inhaled corticosteroids. Pediatrics 89:839-842.
22. Bisgaard, H. 1993. Systemic activity of inhaled topical steroid in toddlers studied by knemometry. Acta Paediatr. 82:1066-1071.
23. Wolthers, O. D., and S. Pedersen. 1993. Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch. Dis. Child. 68:673-676.
24. Karlberg, J., L. Gelander, and K. Albertsson-Wikland. 1993. Distinctions between short- and long-term human growth studies. Acta Paediatr. 83:631-634.
25. Price, J. F. 1993. Effects of asthma and inhaled corticosteroids on growth in children. Summary and conclusions. Eur. Respir. Rev. 3:338-339.
26. Holt, P. R., D. W. Lowndes, E. Smithies, and G. T. Dixon. 1990. The effect of an inhaled steroid on the hypothalamic-pituitary-adrenal axis: which tests should be used? Clin. Exp. Allergy 20:145-149.
27. Bisgaard, H., M. D. Damkjær Nielsen, B. Andersen, P. Andersen, N. Foged, G. Fuglsang, A. Høst, C. Leth, M. Pedersen, I. Pelck, G. Stafanger, and Ø. Østerballe. 1988. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J. Allergy Clin. Immunol. 81:1088-1095.
28. Lemanske, R. F., Jr., and D. B. Allen. 1993. The safety of chronic asthma treatments: continuous beta agonist therapy and prolonged inhaled corticosteroids in childhood asthma. In E. Middleton, Jr., C. E. Reed, R. F. Ellis, N. F. Adkinson, Jr., J. W. Yuninger, and W. W. Busse, editors. Allergy. Principles and Practice, 4th ed., Update No. 15. Mosby-Yearbook, St. Louis, MO. 1-16.
29. Prifits, K., A. D. Milner, E. Conway, and J. W. Honour. 1990. Adrenal function in asthma. Arch. Dis. Child. 65:838-840.
30. Goldstein, D. E., and P. König. 1983. Effect of inhaled beclomethasone dipropionate on hypothalamic-pituitary-adrenal axis function in children with asthma. Pediatrics 72:60-64.
31. Katsunuma, T., A. Akasawa, and Y. Iikura. 1992. Adrenal function of children with bronchial asthma treated with beclomethasone dipropionate. Ann. Allergy 69:529-532.
32. Katz, R. M., G. S. Rachelefsky, S. C. Siegel, S. L. Spector, and A. S. Rohr. 1986. Twice-daily beclomethasone dipropionate in the treatment of childhood asthma. J. Asthma 23:1-7.
33. Tabachnik, E., and Z. Zadik. 1991. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J. Pediatr. 118:294-297.
34. Wyatt, R., J. Waschek, M. Weinberger, and B. Sherman. 1978. Effects of inhaled beclomethasone dipropionate and alternate-day prednisone on pituitary-adrenal function in children with chronic asthma. N. Engl. J. Med. 299:1387-1392.
35. Bhan, G. L., G. M. Gwynn, and J. Morrison Smith. 1980. Growth and adrenal function of children on prolonged beclomethasone dipropionate treatment. Lancet i:96-97.
36. Prahl, P. 1991. Adrenocortical suppression following treatment with beclomethasone dipropionate and budesonide. Clin. Exp. Allergy 21: 145-146.
37. Nassif, E., M. Weinberger, B. Sherman, and K. Brown. 1987. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J. Allergy Clin. Immunol. 80:518-529.
38. Prahl, P., and G. E. Andersen. 1991. Carbohydrate, lipid and glucocorticoid metabolism in children with asthma following treatment with high-dose steroid aerosol. Pediatr. Allergy Immunol. 2:79-82.
39. Prahl, P., T. Jensen, and H. Bjerregaard-Andersen. 1987. Adrenocortical function in children on high-dose steroid aerosol therapy. Allergy 42:541-544.
40. Sherman, B., M. Weinberger, H. Chen-Walden, and H. Wendt. 1982. Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults. J. Allergy Clin. Immunol. 69: 208-212.
41. Smith, M. J., and M. E. Hodson. 1983. Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax 38:676-681.
42. Brown, P. H., G. Blundell, A. P. Greening, and G. K. Crompton. 1991. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir. Med. 85:501-510.
43. Brown, P. H., G. Blundell, A. P. Greening, and G. K. Crompton. 1990. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 45:736-739.
44. Prahl, P., and T. Jensen. 1987. Decreased adreno-cortical suppression utilizing the Nebuhaler for inhalation of steroid aerosols. Clin. Allergy 17:393-398.
45. Hollman, G. A., and D. B. Allen. 1988. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 81:452-455.
46. Caballero, F., and P. Gunczler. 1993. Severe adrenal suppression in a 12 year old induced by beclomethasone dipropionate (abstract). J. Allergy Clin. Immunol. 91:261.
47. Wong, J., and P. Black. 1992. Acute adrenal insufficiency associated with high dose inhaled steroids. B.M.J. 304:1415.
48. Zwaan, C. M., R. J. H. Odink, H. A. Delemarre-Van de Waal, J. E. Dankert-Roelse, and J. A. Bokma. 1992. Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy. Lancet 340: 1289-1290.
49. Civitelli, R. 1993. Biochemical markers of bone turnover. In L. V. Avioli, editor. The Osteoporotic Syndrome. Detection, Prevention, and Treatment, 3rd ed. Wiley-Liss, New York. 39-61.
50. Delmas, P. D. 1993. Markers of bone formation and resorption. In M. J. Favus, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2nd ed. Raven Press, New York. 108-112.
51. Reid, D. M. 1993. Methods of measurement of bone turnover and clinical evaluation of osteoporosis: relevance to asthma and corticosteroid therapy. Respir. Med. 87(Suppl. A):9-14.
52. Pouw, E. M., M. F. Prummel, H. Oosting, C. Roos, and E. Endert. 1991. Beclomethasone inhalation decreases serum osteocalcin concentrations. B.M.J. 302:627-628.
53. Teelucksingh, S., P. L. Padfield, L. Tibi, K. J. Gough, and P. R. Holt. 1991. Inhaled corticosteroids, bone formation and osteocalcin. Lancet 338:60-61.
54. Leech, J. A., R. V. Hodder, D. S. Ooi, and J. Gay. 1993. Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am. Rev. Respir. Dis. 148:113-115.
55. König, P., L. Hillman, C. Cervantes, C. Levine, C. Maloney, B. Douglass, L. Johnson, and S. Allen. 1993. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J. Pediatr. 122:219-226.
56. Ali, N. J., S. Capewell, and M. J. Ward. 1991. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46:160-164.
57. Kerstjens, H. A. M., D. S. Postma, J. J. van Doormaal, A. K. van Zanten, P. L. P. Brand, P. N. R. Dekhuijzen, and G. H. Koëter. 1994. Effects of short term and long term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Thorax 49:652-656.
58. Brattsand, R., A. Thalén, K. Roempke, L. Källström, and E. Gruvstad. 1982. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. Eur. J. Respir. Dis. 63 (Suppl. 122):62-73.
59. Brattsand, R., and A. I. Axelsson. 1992. New inhaled glucocorticosteroids. In P. J. Barnes, editor. New Drugs for Asthma, Vol. 2. 1BC Technical Services, London. 193-208.
60. Barnes, P. J., and S. Pedersen. 1993. Efficacy and safety of inhaled corticosteroids in asthma. Am. Rev. Respir. Dis. 148(Suppl.):S1-S26.
61. Baran, D. 1987. A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br. J. Dis. Chest. 81:170-175.
62. Nicolaizik, W. H., J. L. Marchant, M. A. Preece, J. O. Warner. 1994. Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 150:624-628.
63. Leblanc, P., S. Mink, T. Keistinen, P.A. Saarelainen, N. Ringdal, and S. L. Payne. 1994. A comparison of fluticasone propionate 200 μg/d with beclomethasone dipropionate 400 μg/d in adult asthma. Allergy 49:380-385.
64. Gustafsson, P., J. Tsanakas, M. Gold, R. Primhak, M. Radford, and E. Gillies. 1993. Comparison of the efficacy and safety of inhaled fluticasone 200 μg/d with inhaled beclomethasone dipropionate 400 μg/d in mild and moderate asthma. Arch. Dis. Child. 69:206-211.
65. -1) administered by pressurized inhaler. Respir. Med. 87:609-620.
66. Barnes, N. C., G. Marone, G. U. Di Maria, S. Visser, I. Utama, and S. L. Payne. 1993. A comparison of fluticasone propionate 1 mg daily with beclomethasone dipropionate 2 mg daily in the treatment of severe asthma. Eur. Respir. J. 6:877-884.
67. Lorentzen, K. A., and R. Dahl. 1994. Long-term safety of FP 1 mg daily compared with BDP 2 mg daily in patients with severe asthma (abstract). Eur. Respir. J. 7(Suppl. 18):366s.
68. Fabbri, L., P. S. Burge, L. Croonenborgh, F. Warlies, B. Weeke, A. Ciaccia, and C. Parker on behalf of an International Study Group. 1993. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 48:817-823.
69. Wiebmann, K. J., and M. Trautmann. 1994. Fluticasone propionate (500 μg daily) and flunisolide (1000 mg daily) in the treatment of steroid-naive patients with moderate asthma (abstract). Eur. Respir. J. 7(Suppl. 18):383s.
70. Langdon, C. G., and J. Thompson. 1992. Fluticasone propionate: a comparison with budesonide in adult asthmatic patients. Eur. Respir. J. 5(Suppl. 15):368.
71. Langdon, C. G., and L. J. Capsey. 1994. A comparison of fluticasone propionate and budesonide administered via their respective dry powder delivery devices in adult asthmatics (abstract). Eur. Respir. J. 7(Suppl. 18):366s.
72. Ayres, J. G., T. A. J. Harris, B. Lundbäck, and E. D. Bateman. 1994. A comparison of the safety and efficacy of fluticasone propionate (1 mg/day and 2 mg/day) and budesonide (1.6 mg/day) in the treatment of severe asthma (abstract). Eur. Respir. J. 7(Suppl. 18):366s.
73. Pedersen, S., and G. Fuglsang. 1988. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur. Respir. J. 1:433-435.
74. Brown, P. H., S. P. Matusiewicz, C. Shearing, L. Tibi, A. P. Greening, and G. K. Crompton. 1993. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax 48:967-973.
75. Gove, A., C. Allam, L. C. McFarlane, G. McPhate, C. M. Jackson, and B. J. Lipworth. 1994. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br. J. Clin. Pharmacol. 38:527-532.
76. Grannén, A., R. M. Brundin, A. Ling-Andersson, and S.-Å. Eckernäs. 1994. Suppressive effect of therapeutic doses of fluticasone propionate on the HPA-axis in healthy volunteers (abstract). Eur. Respir. J. 7 (Suppl. 18):382s.
77. Szefler, S. J. 1991. Glucocorticoid therapy for asthma: clinical pharmacology. J. Allergy Clin. Immunol. 88:147-155.
78. O'Callaghan, C., M. Cant, and C. Robertson. 1994. Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? Thorax 49:961-964.
79. Lipworth, B. J. 1995. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 50:105-110.
80. Newhouse, M. T., and H. D. Fuller. 1993. Rose is a rose is a rose? Aerosol therapy in ventilated patients: nebulizers versus metered dose inhalers: a continuing controversy (editorial). Am. Rev. Respir. Dis. 148:1244-1246.
81. Thorsson, L., S. Edsbäcker, and T.-B. Conradson. 1994. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur. Respir. J. 7:1839-1844.
82. Hindle, M., D. Newton, and H. Chrystyn. 1993. Relative bioavailability of salbutamol to the lung following inhalation by a metered dose inhaler and a dry powder inhaler (abstract). Thorax 48:433-434.
83. Hindle, M., A. G. Newton, and H. Chrystyn. 1995. Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique. Chest 107:629-633.
84. Agertoft, L., and S. Pedersen. 1993. Importance of the inhalation device on the effect of budesonide. Arch. Dis. Child. 69:130-133.
85. Agertoft, L., and S. Pedersen. 1994. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir. Med. 88:373-381.
86. Haahtela, T., M. Järvinen, T. Kava, K. Kirviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Perrson, O. Selroos, A. Sovijärvi, B. Stenius-Aarniala, R. Svahn, R. Tammivaara, and L. Laitinen. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.